Article
C–X–C motif chemokine ligand 12: a potential therapeutic target in Duchenne muscular dystrophy
1 Jan 2021
Abstract excerpt
Duchenne muscular dystrophy (DMD) is an X-linked recessive disease caused by a mutant dystrophin protein. DMD patients undergo gradual progressive paralysis until death. Chronic glucocorticoid therapy remains one of the main treatments for DMD, despite the significant side effects. However, its mechanisms of action remain largely unknown. We used bioinformatics tools to identify pathogenic genes involved in DMD...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
